# Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis Pigmentosa

> **NCT02465749** · EARLY_PHASE1 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 404 (estimated)

## Conditions studied

- Retinitis Pigmentosa

## Interventions

- **DRUG:** Continuous oxygen
- **DEVICE:** blue light-absorbing sunglasses
- **DRUG:** Compound thrombosis capsule sig: 1.5g/tid
- **DRUG:** Ginkgo biloba pills sig: 300mg/tid;
- **DRUG:** Vitamin B sig: 10mg/tid
- **DRUG:** Vitamin AD sig: 1 tablet/tid

## Key facts

- **NCT ID:** NCT02465749
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2025-06
- **Final completion:** 2025-06
- **Target enrollment:** 404 (ESTIMATED)
- **Last updated:** 2015-06-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02465749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02465749, "Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis Pigmentosa". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02465749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*